(Q28377106)
Statements
Phase II trial of doxorubicin and paclitaxel plus granulocyte colony-stimulating factor in metastatic breast cancer: an Eastern Cooperative Oncology Group Study (English)
0 references
December 1999
0 references
17
0 references
12
0 references
3828-34
0 references